Fatigue Impacts Quality of Life in People with Spinocerebellar Ataxias

ABSTRACT Background Fatigue is a prevalent and debilitating symptom in neurological disorders, including spinocerebellar ataxias (SCAs). However, the risk factors of fatigue in the SCAs as well as its impact have not been well investigated. Objectives To study the prevalence of fatigue in SCAs, the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Movement disorders clinical practice (Hoboken, N.J.) N.J.), 2024-05, Vol.11 (5), p.496-503
Hauptverfasser: Lai, Ruo‐Yah, Rummey, Christian, Amlang, Christian J., Lin, Chi‐Ying R., Chen, Tiffany X., Perlman, Susan, Wilmot, George, Gomez, Christopher M., Schmahmann, Jeremy D., Paulson, Henry, Ying, Sarah H., Onyike, Chiadi U., Zesiewicz, Theresa A., Bushara, Khalaf O., Geschwind, Michael D., Figueroa, Karla P., Pulst, Stefan M., Subramony, Sub H., Burns, Matthew R., Opal, Puneet, Duquette, Antoine, Ashizawa, Tetsuo, Hamedani, Ali G., Davis, Marie Y., Srinivasan, Sharan R., Moore, Lauren R., Shakkottai, Vikram G., Rosenthal, Liana S., Kuo, Sheng‐Han
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ABSTRACT Background Fatigue is a prevalent and debilitating symptom in neurological disorders, including spinocerebellar ataxias (SCAs). However, the risk factors of fatigue in the SCAs as well as its impact have not been well investigated. Objectives To study the prevalence of fatigue in SCAs, the factors contributing to fatigue, and the influence of fatigue on quality of life. Methods Fatigue was assessed in 418 participants with SCA1, SCA2, SCA3, and SCA6 from the Clinical Research Consortium for the Study of Cerebellar Ataxia using the Fatigue Severity Scale. We conducted multi‐variable linear regression models to examine the factors contributing to fatigue as well as the association between fatigue and quality of life. Results Fatigue was most prevalent in SCA3 (52.6%), followed by SCA1 (36.7%), SCA6 (35.7%), and SCA2 (35.6%). SCA cases with fatigue had more severe ataxia and worse depressive symptoms. In SCA3, those with fatigue had a longer disease duration and longer pathological CAG repeat numbers. In multi‐variable models, depressive symptoms, but not ataxia severity, were associated with more severe fatigue. Fatigue, independent of ataxia and depression, contributed to worse quality of life in SCA3 and SCA6 at baseline, and fatigue continued affecting quality of life throughout the disease course in all types of SCA. Conclusions Fatigue is a common symptom in SCAs and is closely related to depression. Fatigue significantly impacts patients' quality of life. Therefore, screening for fatigue should be considered a part of standard clinical care for SCAs.
ISSN:2330-1619
2330-1619
DOI:10.1002/mdc3.14006